patients taking corticosteroids
Conditions
Interventions
None listed
Sponsors
Saitama Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who received acupuncture treatment at the Department of Oriental Medicine, Saitama Medical University Hospital between April 1, 2013, and October 31, 2024, or at the Department of Oriental Medicine, Kawagoe Clinic between April 1, 2020, and October 31, 2024. 2) Patients who were treated with oral or intravenous steroids. The eligible steroid formulations include hydrocortisone, cortisone, prednisolone, methylprednisolone, triamcinolone, dexamethasone, and betamethasone.
Exclusion criteria
Exclusion criteria: Patients whose steroid use had already ended at the start of acupuncture treatment. Patients using only topical steroids, transdermal patches, or inhaled steroids. Patients with unknown duration of corticosteroid use Patients with an unknown dosage of corticosteroid use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the incidence of acupuncture-related adverse events in patients taking steroids, particularly infections (Infection and Infestation) classified as Grade 2 or higher according to the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, occurring within 2 weeks after an acupuncture session. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Calculate the incidence rate of CTCAE Grade 1 AEs recorded in the medical records of both our department and other departments, per patient and per treatment session. 2.Stratify by the duration and dosage of steroid administration and calculate the AE incidence rates. 3.Calculate crude odds ratios using univariate analysis and subsequently perform logistic regression analysis to identify factors associated with AE occurrence. | — |
Countries
Japan
Contacts
Public ContactMasaki Murahashi
Saitama Medical University Hospital Department of Oriental Medicine
Outcome results
None listed